结核病药物发现的关键挑战:一个视角
Baji Baba Shaik1, Rajshekhar Karpoormath1
1Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal (Westville), Durban 4000, South Africa.
结核病药物开发面临重大障碍,尽管重新开展研究,但很少有化合物进入临床试验. 这一观点强调了开发新型结核病 (TB) 药物的关键挑战和战略.
科学领域:
- 传染性疾病 传染性疾病
- 药用化学 医学化学
- 药物开发 药物开发
背景情况:
- 结核病 (TB) 仍然是全球传染病死亡的主要原因.
- 尽管最近的研发恢复,结核病药物开发历史上面临着忽视.
- 需要改善针对药物敏感和耐药结核病菌株的治疗方法.
研究的目的:
- 概述开发新型结核病药物的主要障碍.
- 讨论克服结核病药物开发挑战的方法.
- 帮助药物化学家创造新的抗结核病候选药物.
主要方法:
- 这种观点综合了结核病药物开发管道上的信息.
- 它回顾了从化合物识别到临床阶段遇到的常见挑战.
- 它探讨了促进潜在结核病药物的进展的策略.
主要成果:
- 每年发现数百种潜在的抗结核化合物,但很少有达到临床开发.
- 在将临床前发现转化为可行的临床治疗中存在重大障碍.
- 更新的研发努力显示出希望,但需要专注的战略来克服消耗.
结论:
- 解决结核病药物开发中的瓶对于打击全球结核病流行病至关重要.
- 了解和减轻发展挑战可以加速提供新的结核病疗法.
- 这项工作旨在指导药物化学家向更有效的结核病药物发现和开发.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Discovery: Overview
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
